CompletedNot Applicable

The Role of the Upper Colliculus in the Idiopathic Blepharospasm

France13 participantsStarted 2019-11-20

Plain-language summary

This pilot study aims at investigating the role of superior colliculus in patients with idiopathic blepharospasm (BSP) de novo, compared to healthy subjects.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non treated idiopathic blepharospasm * Age: 30- 70 years Exclusion Criteria: * Under the following treatments: Botulin toxin, anticholinergic, benzodiazepines, baclofen, beta- and alpha-blockers collyrium * No MRI Contraindication

What they're measuring

Visual pathways fMRI

Timeframe: In a five months period after inclusion

Trial details

NCT IDNCT03903341

SponsorUniversity Hospital, Grenoble

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-19

View on ClinicalTrials.gov More Blepharospasm, Benign Essential trials